Physician

Abdul Rahman Alchaki, M.D.

According to 2025 Medicare claims, Abdul Alchaki, M.D. (NPI: 1821418666) practices neurology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is TMH PHYSICIAN ASSOCIATES PLLC (NPI: 1275779225; TIN: 300520570) and primary practice location at 77030-2725. Alchaki is affiliated with the Houston Methodist Coordinated Care (ACO ID: A3473), participating under the MSSP model.

Alchaki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 104 traditional Medicare patients, billed 205 HCPCS/CPT codes, and received $22,543 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 130 prescription claims across 49 beneficiaries totaling $122,927 in drug costs, led by Levetiracetam (Levetiracetam). Open Payments data shows 74 records totaling $14,976. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $12,553 and ending at $22,543. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $529 to $122,927. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$15K$31K2019 Medicare payment: $12,553 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $13,524 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $27,703 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $30,927 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $12,240 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $22,543 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019117168$12,553
2020155242$13,524
2021205328$27,703
2022220385$30,927
2023139177$12,240
2024104205$22,543

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$466K$932K2017 Drug cost: $529 (USD; Tot_Drug_Cst)2018 Drug cost: $29,575 (USD; Tot_Drug_Cst)2019 Drug cost: $378,217 (USD; Tot_Drug_Cst)2020 Drug cost: $347,244 (USD; Tot_Drug_Cst)2021 Drug cost: $581,224 (USD; Tot_Drug_Cst)2022 Drug cost: $931,625 (USD; Tot_Drug_Cst)2023 Drug cost: $910,928 (USD; Tot_Drug_Cst)2024 Drug cost: $122,927 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R11$529
20183678$29,575
2019125450$378,217
2020135857$347,244
20211801,273$581,224
20221951,650$931,625
20232031,278$910,928
202449130$122,927

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1111$163
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes3842$137
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2848$134
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes3251$91

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LevetiracetamLevetiracetam19680$340

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.74$14,976Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdul Rahman Alchaki, M.D.?

Tedicare shows public-source Medicare data for Abdul Rahman Alchaki, M.D. (NPI 1821418666), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Rahman Alchaki, M.D. have ACO affiliation data?

Abdul Rahman Alchaki, M.D. is shown with ACO affiliation data for Houston Methodist Coordinated Care (MSSP, ACO ID A3473).

What billing organization is linked to Abdul Rahman Alchaki, M.D.?

Abdul Rahman Alchaki, M.D. is linked to TMH PHYSICIAN ASSOCIATES PLLC (billing NPI 1275779225) in the available physician profile data.

Does Abdul Rahman Alchaki, M.D. have Open Payments data?

Abdul Rahman Alchaki, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.